Antibody Testing for COVID-19: Can It Be Used as a Screening Tool in Areas With Low Prevalence?

Authors

Sweta Mathur, Case Western Reserve University

Document Type

Editorial

Publication Date

5-15-2020

Keywords

antibody testing, COVID-19, SARS-CoV-2, prevalence, sensitivity, specificity, positive predictive value

Publication Title

American Journal of Clinical Pathology

Rights

© American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chor...) This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

Recommended Citation

Gagan Mathur, Sweta Mathur, Antibody Testing for COVID-19: Can It Be Used as a Screening Tool in Areas With Low Prevalence?, American Journal of Clinical Pathology, Volume 154, Issue 1, July 2020, Pages 1–3, https://doi.org/10.1093/ajcp/aqaa082